drugset / Trial / NCT00143130
Pregabalin In Partial Seizures Extension Study
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To evaluate long-term efficacy and safety of pregabalin (150 to 600mg/day) as adjunctive treatment in patients with partial seizures.
Timeline
- Start
- 2005-04
- Primary completion
- —
- Completion
- 2007-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pregabalin | Small molecule | 150 mg | — |
| Subject | Pregabalin | Small molecule | 600 mg | — |